About Scientific Collaborations
cliniMARK
Thousands of circulating proteins have been shown to be hallmarks of emerging disease, response to treatment, or a patients’ prognosis. The identification of these small molecule biomarkers holds a great promise for significant improvement of personalized medicine based on simple blood tests.
To increase the number of clinically validated biomarkers, rather than further increasing the number of biomarker discovery studies, CliniMARK will improve the quality and reproducibility of studies and establish a coherent biomarker development pipeline from discovery to market introduction.
To increase the number of clinically validated biomarkers, rather than further increasing the number of biomarker discovery studies, CliniMARK will improve the quality and reproducibility of studies and establish a coherent biomarker development pipeline from discovery to market introduction.
AARC2
The goal of AARC2 is to design an AAI framework to develop interoperable AAI, to enable researchers to access the whole research and infrastructure service portfolio with one login.
EOSCpilot
The EOSCpilot project will support the first phase in the development of the European Open Science Cloud (EOSC)...
SPIDIA4P
Molecular in vitro diagnostics and biomedical research have allowed great pro- gress in ...
Completed Projects
How to partner up
PhenoMeNal
During the next 10 years, a significant number of the 742,000,000 European citizens will have their genome determined routinely.
RItrain
The overarching goal of RItrain is to identify the competency requirements for the leadership of European research infrastructures (RI) and design a training programme to fulfil these requirements. Our highest priority is those professionals who are already working in research infrastructures, including directors, coordinators, senior project managers, legal representatives, heads of Finance and HR, and heads of communication.
RD-Connect
Despite examples of excellent practice, rare diseases (RD) research is still mainly fragmented by data and diseaese types.
EMTRAIN
EMTRAIN will establish a pan-European platform for education and training covering the whole lifecycle of medicines from basic research through clinical development to pharmaco-vigilance.
EGI-Engage
This BBMRI-ERIC EGI (European Clinical Research Infrastructures Network) Competence Centre focuses on helping BBMRI-ERIC to bridge the implementation of big data storage in combination with data analysis and data federation using EGI federated cloud infrastructure.
CY-Biobank
The upgrading of MMRC into a CoE and its close partnership with the named Advanced Partners is a safe and sound strategy that will assist Cyprus over the next decade to enter large European networks and participate at ongoing and future epidemiological studies with mutual benefit to the Cypriot and the European patients.
ADOPT BBMRI-ERIC
The ADOPT BBMRI-ERIC (implementAtion anD OPeration of the gateway for healTh into BBMRI-ERIC) proposal aims at boosting and accelerating implementation of BBMRI-ERIC and its services.
Its main deliverables are designed to complete or launch the construction of key Common Services of the Research Infrastructure as required for European Strategy Forum on Research Infrastructure-(ESFRI) -projects ‘under implementation’, reflecting the targets of the European Research Area (ERA).
Its main deliverables are designed to complete or launch the construction of key Common Services of the Research Infrastructure as required for European Strategy Forum on Research Infrastructure-(ESFRI) -projects ‘under implementation’, reflecting the targets of the European Research Area (ERA).
B3Africa
B3Africa (Bridging Biobanking and Biomedical Research across Europe and Africa) will dramatically improve and facilitate the development of better predictive, preventive and personalised healthcare worldwide.
The rapidly evolving African biobanks are an invaluable resource: The African population has the greatest genomic diversity on the planet and represents an incredible resource of information to advance biomedical research.
The rapidly evolving African biobanks are an invaluable resource: The African population has the greatest genomic diversity on the planet and represents an incredible resource of information to advance biomedical research.
BBMRI-LPC
BBMRI-LPC unites the large study sets of the European Biobanking and Biomolecular resources Research Infrastructure (BBMRI) and the International Agency for Research on Cancer (IARC), thus achieving a worldwide unique scale of integration.
BioMedBridges
Lead by European Molecular Biology Laboratory: BioMedBridges (Building data bridges and services between biological and medical infrastructures in Europe) will form a cluster of the emerging biomedical sciences research infrastructures (BMS RIs) and construct the data and service bridges needed to connect them.
CORBEL
CORBEL will establish a collaborative framework of shared services between the ESFRI Biological and Medical Research Infrastructures that transform the European research community from discovery of basic biological mechanisms to applied medical translation – through the provision of a unified interface, aligned services and coordinated user access to a range of advanced technology platforms.
